Found 0 matching trials
HIPEC as Neoadjuvant Treatment for Resectable Pancreatic Adenocarcinoma
PHASE2This single-center, prospective proof-of-concept study is designed to evalu...
Location
Carolinas Medical Center
Safety of Breast-Conserving Surgery for Multifocal or Multicentric Breast Cancer
N/AThe objective of this observational study is to evaluate the oncological sa...
Location
Multiple Locations
Individualized Locoregional Treatment of Initially Biopsy-proven Node-positive Breast Cancer After Primary Systemic Therapy
PHASE3In clinically node-positive (cN+) breast cancer, preoperative systemic ther...
Location
Multiple Locations
Efficacy of HIPEC in the Treatment of Locally Advanced Gastric Cancer After radIcal Gastrectomy With D2
PHASE3HIPEC-01 is a prospective, open, randomized multicenter phase III clinical ...
Location
Chinese PLA General Hospital
Chemotherapy Before Surgery in Treating Patients With High Grade Upper Urinary Tract Cancer
PHASE2This phase II trial studies how well giving chemotherapy before surgery wor...
Location
University of Alabama at Birmingham Cancer Center
Excision of Lymph Node Trial (EXCILYNT) (Mel69)
NAThe purpose of this study is to find out if removing only the cancerous lym...
Comparison of Segmentectomy Versus Lobectomy for Lung Adenocarcinoma ≤ 2cm
N/AThis study aims to evaluate the superiority in recurrence-free survival of ...
Location
Shanghai Pulmonary Hospital
Perioperative Enfortumab Vedotin (EV) Plus Pembrolizumab (MK-3475) Versus Neoadjuvant Chemotherapy for Cisplatin-Eligible Muscle Invasive Bladder Cancer (MIBC) (MK-3475-B15/ KEYNOTE-B15 / EV-304)
PHASE3The purpose of this study is to assess the antitumor efficacy and safety of...
Status
Active Not Recruiting
Location
Mayo Clinic in Arizona - Phoenix ( Site 0043)
Carbon Suspension vs. Metallic Marker for Axillary Lymph Node Marking in Breast Cancer After Neoadjuvant Therapy
NAThis single-center, randomized study aims to compare the intraoperative det...
Location
St. Petersburg State University
Neoadjuvant SBRT Followed by Sintilimab Plus Chemotherapy for N3-Positive NSCLC
PHASE2This is a Phase II clinical trial evaluating the efficacy and safety of a n...
Location
Sun Yat-sen University Cancer Center